![](/fileadmin/_processed_/csm_Biotalys_platform_b35a9cfabc.png)
Biotalys starts field testing for biofungicide
The protein-based biofungicide is under development of the company’s Agrobody technology platform for sustainable biocontrols as an alternative...
![](/fileadmin/Content/NewsAndStories/2024/Enk_freitag.png)
Friday: CRISPR screen highlights genes behind T cell plasticity in autoimmunity
Pro-inflammatory CD4-positive T cells are major drivers of autoimmune diseases, yet therapiesmodulating T cell phenotypes to promote an...
![](/fileadmin/_processed_/csm_EB224_ECC03_tg_4a0c378aa9.png)
Full house at European Cluster Conference
Compared to the USA and China, EU biotech clusters appear to be dwarfed by the lack of industry-specific support in terms of access to funding,...
![](/fileadmin/_processed_/csm_Product_Award_winners_88844c23d2.png)
SLAS Europe 2024 honours products with most impact
Two companies were selected by the SLAS Europe 2024 jury from 13 applicants and six finalists as winners of this year's Product Award in Barcelona:...
![](/fileadmin/Content/NewsAndStories/2024/Bildschirmfoto_2024-07-09_um_09.31.12.png)
EMA-Gate: PharmaMar wins suit against EMA
The European Commission has corrected its decision C(2018) 4831 from 2018 not to grant marketing authorisation for Aplidin (plitidepsin), a peptidic...
![](/fileadmin/_processed_/csm_anacura_griet_ohmxbio_104d007f0f.jpg)
Anacura aquires Ohmx.bio
Anacura, a Ghent-based company offering medical and pharmaceutical analytical services, announces the acquisition of OHMX.bio, a also...
![](/fileadmin/_processed_/csm_Labmate-currency-2317703_1280_be218675b3.jpg)
LabGenius raises £35m to expand its antibody discovery platform
The investment brings LabGenius’ total funding to £58m. The new round was led by new investor M Ventures (Merck’s venture capital). New investors...